Writing a thesis can be an arduous and challenging task, especially when delving into complex topics

such as systemic lupus erythematosus (SLE). This autoimmune disease presents multifaceted
challenges that demand extensive research, critical analysis, and coherent presentation of findings.

Navigating through the vast literature, understanding the intricate mechanisms underlying SLE, and
synthesizing original insights can be overwhelming for many students. Moreover, the pressure to
adhere to academic standards and meet deadlines adds another layer of stress to the process.

In such circumstances, seeking professional assistance becomes imperative. ⇒ BuyPapers.club ⇔

offers a reliable solution for students grappling with the complexities of writing a thesis on systemic
lupus erythematosus. Our team of experienced writers specializes in medical research and is well-
equipped to tackle the intricacies of this subject.

By entrusting your thesis to ⇒ BuyPapers.club ⇔, you can alleviate the burden and ensure a high-
quality, well-researched document. Our writers will meticulously craft your paper, adhering to your
instructions and delivering within your specified timeframe.

Don't let the daunting task of writing a thesis on systemic lupus erythematosus overwhelm you. Trust
⇒ BuyPapers.club ⇔ to provide the expertise and support you need to excel in your academic
pursuits. Place your order today and take the first step towards academic success.
Anti-nuclear antibodies (ANA) and anti-double stranded DNA (anti-dsDNA) are reliable biomarkers
for diagnosing SLE. This is 100% legal. You may not submit downloaded papers as your own, that is
cheating. Also you. Paper should be a substantial original Article that involves several techniques or
approaches, provides an outlook for. Note that from the first issue of 2016, this journal uses article
numbers instead of page numbers. To browse Academia.edu and the wider internet faster and more
securely, please take a few seconds to upgrade your browser. The types of medications required will
depend on the symptoms. Nearly all patients with lupus will require at least one medication, while
many patients need several medications. We use cookies to create the best experience for you.
Expand 15 PDF Save Interferons and systemic lupus erythematosus: Pathogenesis, clinical features
and treatments in interferon-driven disease. There are few categories of lupus for instance, lupus
dermatitis or cutaneous lupus erythematosus (CLE) that affects the skin and causes malar rash,
discoid lupus erythematosus (DLE) as well as systemic lupus erythematosus that causes damage to
single or multiple internal organs. Cell nucleic acids are then exposed to the immune system and
activate dendritic cells via toll-like receptors, to produce type-I IFN. Florez-Suarez P. Coral-
Alvarado P. Mendez-Patarroyo Gerardo Quintana-Lopez Medicine SAGE Open Medicine 2019
TLDR The role of the innate immune system in rheumatoid arthritis and systemic lupus
erythematosus pathophysiology is not only important in early stages but is essential to maintain the
immune response and to allow disease progression. Drakoulogkona A. Barbulescu I. Rica A.
Mu?etescu P. Ciurea Medicine Current health sciences journal 2011 TLDR The study reveals the fact
that cardiovascular risk factors such as hypertension, hyperlipidaemia and antiphospholipid
syndrome are associated with a higer rate of mortality and an evolution to end-stage renal disease.
Dendritic cells also produce BAFF, which is necessary for B-cell activation and survival, and activate
T cells, through the presentation of nuclear self-antigens. Atallah Medicine The Cochrane database
of systematic reviews 2006 TLDR This systematic review found one randomised controlled trial
with a small number of patients in the different clinical subgroups of neurological manifestation that
seems that cyclophosphamide is more effective in the treatment of neuropsychiatric involvement in
systemic erythematosus lupus compared with methylprednisolone. Semantic Scholar is a free, AI-
powered research tool for scientific literature, based at the Allen Institute for AI. Antiphospholipid
antibodies, which include lupus anticoagulant, anti-cardiolipin antibodies, and anti-?2 glycoprotein 1
antibody, are important indicators of vascular inflammation and thromboembolic risk. Journal of
Otorhinolaryngology, Hearing and Balance Medicine (JOHBM). Recently, the first data were
published on the use of an anti-CD19 CAR-T cell-based strategy in a patient with refractory SLE.
This observation suggested that plasma cell depletion might be a more effective target in SLE
therapy. This list includes such the identification of relevant genes, as well as how these become
activated in early auto immune activity, causing the disease and involving both the inborn and
acquired immune systems that humans have. A female-to-male ratio of approximately 4:1 occurs
before puberty and after menopause, with a ratio of 8:1 between onset and loss of estrogen cycles. In
individuals with a genetic predisposition, and with the contribution of environmental factors, there is
an accumulation of apoptotic cells and activation of NET production, by neutrophils. Both innate
and adaptive immunity participate in the pathogenesis of SLE. Accapezzato D, Caccavale R, Paroli
MP, Gioia C, Nguyen BL, Spadea L, Paroli M. The damage is due to the inflammation that is caused
by direct antibody reaction to the body tissues as well the deposition of immune complexes. Cell
nucleic acids are then exposed to the immune system and activate dendritic cells via toll-like
receptors, to produce type-I IFN. In addition, the high price of the new drugs may not be sustainable
in the long term in most countries; finally, it has not yet been clarified for how long the new drugs
should be administered. As pointed out earlier, the reduction in steroids is a particularly important
recommendation, although they remain an important and often unavoidable therapeutic adjunct.
These ancestral structures can release high quantities of mitochondrial DNA (mtDNA) after
destruction, following cell apoptosis. Expand 29 Save GPs have key role in shared care of patients
with SLE. M. Amissah-Arthur C. Gordon Medicine Practitioner 2009 TLDR The diagnosis of SLE is
traditionally based on a combination of clinical features and laboratory findings and any patient with
suspected clinical features of lupus should be investigated for the presence of autoantibodies.
International Journal of Molecular Sciences. 2023; 24(7):6578. A subtype of neutrophils, called low-
density granulocytes (LDG), is highly represented in the peripheral blood of SLE patients. These
include, assessing whether the side effects of the newly listed agents are acceptable, compared with
steroids and conventional therapies. Expand 623 PDF 1 Excerpt Save Manifestations of systemic
lupus erythematosus. M. Cojocaru I. Cojocaru I. Silo?i C. Vrabie Medicine Maedica 2011 TLDR
Systemic lupus erythematosus is a chronic, multifaceted autoimmune inflammatory disease that can
affect any part of the body and requires clinical and serologic criteria for diagnosis. You will be able
to get a quick price and instant permission to reuse the content in many different ways. Disease
activity is assessed by the SLE Disease Activity Index-2000 (SLEDAI-2K), British Isles Lupus
Activity Group 2004 (BILAG 2004), and Physician Global Assessment (PGA). Upload Read for
free FAQ and support Language (EN) Sign in Skip carousel Carousel Previous Carousel Next What
is Scribd. Expand 8 PDF 2 Excerpts Save Cyclophosphamide versus methylprednisolone for treating
neuropsychiatric involvement in systemic lupus erythematosus. V. Trevisani A. A. Castro Neves Neto
Jf A. Most recent studies have reported treatment-related mortality to be less than 5%, falling
significantly from the initial studies. Next Article in Journal Cognitive Decline in Early and
Premature Menopause. The highest incidence has been reported in North America, while countries in
sub-Saharan Africa, Europe, and Australia have a lower incidence. Symptoms experienced include
extreme fatigue, skin rashes, weight loss and fever ( Lupus Health Centre, 2012) Kim et al ( 1999)
also described respiratory distress in adults with the condition. Journal of Cardiovascular
Development and Disease (JCDD). Expand 92 PDF 2 Excerpts Save. 1 2 3 4 5. Related Papers
Showing 1 through 3 of 0 Related Papers Figures and Tables 60 Citations 55 References Related
Papers Stay Connected With Semantic Scholar Sign Up What Is Semantic Scholar. Expand 20 PDF
Save Failure of Tolerance to Autoimmunity, Systemic Lupus Erythematosus Aqsa Medicine 2019
TLDR It is hypothesized that mutation in exon 2 of FOXP3 is involved in causing SLE, which is an
important transcriptional Factor of Regulatory T cells (Tregs), thought to be involved in the
dysregulation of T cell production and functional abilities. Antibodies are proteins that normally help
protect the body from invaders, like viruses and bacteria. Kimberley is particularly concerned with
the auto immune reaction, as discusses such things as the possibility of finding new markers for both
immune activation and any deviation. ( page 651) This he says would result in changes in
management to a more effective model. All articles published by MDPI are made immediately
available worldwide under an open access license. No special. However, post hoc analysis
considering the results, taking into account NSAID use, showed that all outcome measures improved,
even though the primary endpoint had not yet been achieved. IFNs play a pivotal role in defense
against pathogens. A debated issue is the pathogenetic role of autoantibodies. This observation
suggested that plasma cell depletion might be a more effective target in SLE therapy. It also has a
low cost, that makes it usable even in low-income geographic areas. However, because CD38 is
expressed by other cells of the immune system important for pathogen defense and
immunoregulation, alternative strategies to target plasma cells in SLE should be pursued. Note that
from the first issue of 2016, this journal uses article numbers instead of page numbers. A female-to-
male ratio of approximately 4:1 occurs before puberty and after menopause, with a ratio of 8:1
between onset and loss of estrogen cycles. Materials and Methods: This study was carried out in the
Department of pathology in collaboration with the department of medicine,, Regional Institute of
Medical Scinces, Imphal, Manipur. CR of both complications following thymectomy and allogeneic
haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA). There is a peak age of
onset in young women between their late teens and early 40s and women to men ratio of 9:1.
We use cookies to create the best experience for you. To browse Academia.edu and the wider
internet faster and more securely, please take a few seconds to upgrade your browser. Note that from
the first issue of 2016, this journal uses article numbers instead of page numbers. Cell nucleic acids
are then exposed to the immune system and activate dendritic cells via toll-like receptors, to produce
type-I IFN. However, the new drugs available to date are still an adjunct to conventional therapy,
which is known to be toxic in the short and long term. Davis Published in Rheumatology 27 March
2017 Medicine, Biology TLDR The immunological changes that characterize this form of
autoimmunity are described and the major leucocytes that are essential for disease progression are
discussed, together with key mediators that propagate the immune response and drive the
inflammatory response in SLE. Subsequently, four additional patients with SLE, presenting with a
form of disease refractory to standard therapy, were treated. Pregnancy outcome appears to be worse
in people with SLE whose disease flares up during pregnancy. Type-I IFN is induced by the
activation of pathogen recognition receptors (PRRs) such as toll-like receptors (TLRs), retinoic acid-
inducible gene I (RIG-I), and melanoma differentiation-associated protein 5 (MDA5). Boumpas
Medicine Annals of the rheumatic diseases 2010 TLDR Neuropsychiatric manifestations in SLE
patients should be first evaluated and treated as in patients without SLE, and secondarily attributed
to SLE and treated accordingly. Common neuropsychiatric manifestations of SLE include cognitive
dysfunction, mood disorder, cerebrovascular disease, seizure, polyneuropathy, anxiety disorder,
psychosis, depression, and in some extreme cases personality disorder. It is stated that ( page 650)
both the inflammatory and non-inflammatory damage caused to the body’s various organs, is due to
the immune system and its pathogenic role in SLE. The earliest evidence suggesting that type one
interferon could play a key role in the genesis of SLE in humans, came from the observation that
patients treated with IFN. Diagnosis is based on clinical assessment supported by investigations,
including the fi nding of autoantibodies. For the missing item, see the original print version of this
publication. There is a peak age of onset in young women between their late teens and early 40s and
women to men ratio of 9:1. However, the presence of ANAs is not exclusive to SLE. Women,
African-Americans, and Hispanics are more likely to develop SLE. These in turn may induce B cells
to produce anti-DNA antibodies. TULIP-1 included an additional lower dose of anifrolumab of 150
mg. It has also been observed that sequences of mtDNA are analogous to those of bacteria and
therefore able to activate TLRs. However, there were numerical improvements in the CRR achieved
by the IR group compared with placebo (45.5% vs. 31.1%), and in the sustained reduction in GC
dose (55.6% vs. 33.3%) in the same group. Accapezzato D, Caccavale R, Paroli MP, Gioia C,
Nguyen BL, Spadea L, Paroli M. There was no significant difference in the percentages of patients
who reached the primary endpoint between the anifrolumab 300 mg group and the placebo group
(36% vs. 40% of patients, respectively), out of a total of 364 subjects who completed the study.
People with lupus can have times of very active disease, called a flare, and times where the disease is
mostly quiet, called remission. Table 2 shows the innovative therapies that are still under
investigation for possible future treatment of SLE. 7. Conclusions SLE is a disease whose genesis is
not yet well understood. Expand PDF Save Bidirectional crosstalk between dysbiotic gut microbiota
and systemic lupus erythematosus: What is new in therapeutic approaches. Expand 623 PDF 1
Excerpt Save Manifestations of systemic lupus erythematosus. M. Cojocaru I. Cojocaru I. Silo?i C.
Vrabie Medicine Maedica 2011 TLDR Systemic lupus erythematosus is a chronic, multifaceted
autoimmune inflammatory disease that can affect any part of the body and requires clinical and
serologic criteria for diagnosis. Earlier diagnosis and more effective treatment options have signifi
cantly improved 5-, 10-, and 20-year survival rates. Such genetically engineered cells are called
chimeric antigen receptor T cells (CAR-T).
Demographic and haematological parameters at diagnosis and the last follow-up, disease
manifestations, organ involvement and clinical hematological complications were recorded. For the
missing item, see the original print version of this publication. Accapezzato D, Caccavale R, Paroli
MP, Gioia C, Nguyen BL, Spadea L, Paroli M. Lupus can be drug induced, can occur in babies born
to women who have Sjogren’s Disease or can be confined to the skin. This cytokine is responsible for
activation of specific genes for pro-inflammatory factors by target cells (IFN signature). Funding
This research received no external funding. The primary endpoint was the achievement of SRI-4 at
week 52. Other test including routine urine examination, kidney function test,ANA (Antinuclear
antibodies) test and Anti-ds DNA screening metl hod were performed to correlate the findings along
with the haematological findings. Although the development of these host-dangerous cells is
controlled by immunological tolerance systems, such as clonal deletion or induction of peripheral
anergy, these control mechanisms can sometimes fail. Self-reactive B cells are then activated to
produce antibodies, and differentiate into long-lived plasma cells, localized in niches in the bone
marrow, which are an additional source of autoantibodies. The immune system attacks the body and
creates inflammation in the skin, joints, kidneys, lungs, nervous system, and other organs of the body.
The highest incidence has been reported in North America, while countries in sub-Saharan Africa,
Europe, and Australia have a lower incidence. In the case of lupus the results of this attack are
widespread and involve such things as joint damage, inflammation of tendons and the whole
connective tissue system as well as organs. It should be noted, however, that pDCs may have also a
tolerogenic function, through the generation of regulatory T cells (Treg). Conflicts of Interest The
authors declare no conflict of interest. A key role in the generation of these autoantibodies is played
by toll-like receptors (TLRs). In BLISS-52, enrolled subjects were randomized to receive standard
therapy plus belimumab, administered intravenously, or placebo, every 4 weeks, with a loading dose
administered at week 2. Atallah Medicine The Cochrane database of systematic reviews 2006 TLDR
This systematic review found one randomised controlled trial with a small number of patients in the
different clinical subgroups of neurological manifestation that seems that cyclophosphamide is more
effective in the treatment of neuropsychiatric involvement in systemic erythematosus lupus
compared with methylprednisolone. Dendritic cells also produce BAFF, which is necessary for B-cell
activation and survival, and activate T cells, through the presentation of nuclear self-antigens.
Serological tests revealed positive antinuclear antibody and anti double-stranded DNA tests. Journal
of Experimental and Theoretical Analyses (JETA). This article focuses on the latest research in SLE’s
epidemiology, diagnosis methods, and treatment strategies. Expand 623 PDF 1 Excerpt Save
Manifestations of systemic lupus erythematosus. M. Cojocaru I. Cojocaru I. Silo?i C. Vrabie
Medicine Maedica 2011 TLDR Systemic lupus erythematosus is a chronic, multifaceted autoimmune
inflammatory disease that can affect any part of the body and requires clinical and serologic criteria
for diagnosis. Ayyappan Robert Z. Harms J. Buckner N. Sarvetnick Medicine, Biology Frontiers in
Immunology 2019 TLDR Changes in the levels and relationships between ARFs link microbial
exposure and SLE, and approaches to reduce microbial exposure or to improve barrier function may
provide therapeutic strategies for SLE patients. International Journal of Turbomachinery, Propulsion
and Power (IJTPP). Over 90% survive for more than 10 years Download Free PDF View PDF See
Full PDF Download PDF Loading Preview Sorry, preview is currently unavailable. Both innate and
adaptive immunity participate in the pathogenesis of SLE. McAlindon Medicine Current Opinion in
Rheumatology 2000 TLDR Although once considered rare, SLE now appears to be relatively
common in certain subsets of the population, and considerable publicity for this disorder as a “silent
killer” has heightened public awareness and may have contributed to the increases in the number of
individuals reporting this diagnosis in surveys. Accapezzato, Daniele, Rosalba Caccavale, Maria Pia
Paroli, Chiara Gioia, Bich Lien Nguyen, Luca Spadea, and Marino Paroli. These receptors can also
be activated by endogenous nucleic acids present in NETs.
Feature papers represent the most advanced research with significant potential for high impact in the
field. A Feature. Self-reactive B cells are then activated to produce antibodies, and differentiate into
long-lived plasma cells, localized in niches in the bone marrow, which are an additional source of
autoantibodies. In individuals with a genetic predisposition, and with the contribution of
environmental factors, there is an accumulation of apoptotic cells and activation of NET production,
by neutrophils. Expand 215 Save Systemic lupus erythematosus D. D'cruz M. Khamashta G. Hughes
Medicine The Lancet 2007 601 Save Clinical profile, management and outcome of lupus. T. Miah M.
A. Haque T. Mahmood B. Tarafder Medicine Mymensingh Medical Journal 2008 TLDR Outcome
was better in the patients who were diagnosed and treated early and after appropriate management
52% patients leading a normal life with medication, 30% patients had a fluctuating course, 9%
patients died and 9% lost follow up. The entry criterion consists of antinuclear antibody (ANA)
positivity on at least one occasion. The goal of treatment is to ease symptoms. This article will
review information on the general approach to SLE therapy, focusing on currently approved
therapies and novel approaches that might be used in the future. To browse Academia.edu and the
wider internet faster and more securely, please take a few seconds to upgrade your browser. T-helper
1 (Th1) cells play a central role in the pathogenesis of SLE, by promoting oxidative stress related to
IFN. To date, more than 300 patients have received autologous transplantation for SLE. After this
protocol modification, TULIP-2 met the primary endpoint, as 47.8% of patients on anifrolumab,
compared with 31.5% in the placebo group, responded according to the above BICLA criteria.
Regulatory T cells (Tregs) are critical in maintaining peripheral tolerance to self-antigens. Anti-
extractable nuclear antigen (ENA) antibodies are more specific than ANA for the diagnosis of SLE.
A debated issue is the pathogenetic role of autoantibodies. The identification of the key role played
by type-I IFN has given further impetus to research. Visit our dedicated information section to learn
more about MDPI. Expand 8 PDF 2 Excerpts Save Cyclophosphamide versus methylprednisolone
for treating neuropsychiatric involvement in systemic lupus erythematosus. V. Trevisani A. A. Castro
Neves Neto Jf A. Baumgartner Lisa Francis Fatme Allam P. Phillips A. Perl Medicine Journal of
Rheumatology 2010 TLDR 6 women who developed active SLE satisfying American College of
Rheumatology diagnostic criteria with life-threatening manifestations after receiving TNF blockade
for treatment of RA or PsA are described. We use cookies to create the best experience for you. CR
of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but
persistence of antinuclear antibodies (ANA). This cytokine is responsible for activation of specific
genes for pro-inflammatory factors by target cells (IFN signature). It is stated that ( page 650) both
the inflammatory and non-inflammatory damage caused to the body’s various organs, is due to the
immune system and its pathogenic role in SLE. Note that from the first issue of 2016, this journal
uses article numbers instead of page numbers. The syndrome is real in its existence-although hidden
behind obstacles, cumbersome for patients and clinicians, and rebellious for scientists. It would be an
interesting study to look at predicted advances in the light of recent research and also to look back
and make comparisons in 2026. The major findings included anemia, leucopenia, lymphopenia and
thrombocytopenia. In the case of lupus the results of this attack are widespread and involve such
things as joint damage, inflammation of tendons and the whole connective tissue system as well as
organs. International Journal of Molecular Sciences. 2023; 24(7):6578. Expand 92 PDF 2 Excerpts
Save. 1 2 3 4 5. Related Papers Showing 1 through 3 of 0 Related Papers Figures and Tables 60
Citations 55 References Related Papers Stay Connected With Semantic Scholar Sign Up What Is
Semantic Scholar. The primary endpoint was the achievement of SRI-4 at week 52. Kur-Zalewska W.
Tlustochowicz Medicine 2012 TLDR W artykule przedstawiono role lekow biologicznych w leczeniu
TRU, w tym obecnie stosowanych (belimumab i rytuksy mab) oraz ocenianych w badaniach
klinicznych.
A detailed history along with a clinical general examination was followed by peripheral blood
examination and bone marrow aspiration to find out the effect of the disease on the haematological
system. Expand 469 1 Excerpt Save Targeted therapies in systemic lupus erythematosus: successes,
failures and future B. Petri Medicine Current opinion in rheumatology 1994 Case reports, case series,
and analytical clinical research studies continue to define and refine our understanding of the clinical
presentation of lupus and its evolution over time. International Journal of Translational Medicine
(IJTM). Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Expand
PDF Save. 1 2 3 4 5. 55 References Citation Type Has PDF Author More Filters More Filters Filters
Sort by Relevance Sort by Most Influenced Papers Sort by Citation Count Sort by Recency
Guidelines for referral and management of systemic lupus erythematosus in adults. You can
download the paper by clicking the button above. Results: Majority of the cases were in the age
group of 21-30 years and 21 patients were of the female gender. However, post hoc analysis
considering the results, taking into account NSAID use, showed that all outcome measures
improved, even though the primary endpoint had not yet been achieved. Paper should be a
substantial original Article that involves several techniques or approaches, provides an outlook for.
The major findings included anemia, leucopenia, lymphopenia and thrombocytopenia. In this phase
III study, patients with class III, IV (with or without class V), or V LN were treated intravenously
with belimumab or placebo, along with standard therapy. Neuropsychiatric syndromes can result
after SLE affects CNS or peripheral nervous system. Please let us know what you think of our
products and services. It has also been observed that sequences of mtDNA are analogous to those of
bacteria and therefore able to activate TLRs. Intravenous immunoglobulins may be used to control
SLE with organ involvement or vasculitis. Moreover, several treatment therapies have also been
proposed to treat SLE. Rastin Medicine Journal of Cellular Biochemistry 2017 TLDR The results of
the current study suggest that vitamin D3 could exert some of its immunomodulatory effects in SLE
patients via affecting the expression levels of some TLRs. Although quantitative and qualitative
differences in Tregs have been described in SLE, studies to date have shown conflicting results, and
their role in SLE is still undefined. Feature papers are submitted upon individual invitation or
recommendation by the scientific editors and must receive. Treatment includes corticosteroids and
anti-malarial drugs. We use cookies to create the best experience for you. In addition, no significant
response in the anifrolumab 150 mg group was observed. T-follicular helper (Tfh) cells are located in
germinal centers and extrafollicular foci. Expand 66 PDF Save T cell signaling abnormalities
contribute to aberrant immune cell function and autoimmunity. Vaishali R. Moulton G. Tsokos
Biology, Medicine Journal of Clinical Investigation 2015 TLDR A better understanding of signaling
and gene regulation defects in SLE T cells will lead to the identification of specific novel molecular
targets and predictive biomarkers for therapy. Expand 20 PDF Save Failure of Tolerance to
Autoimmunity, Systemic Lupus Erythematosus Aqsa Medicine 2019 TLDR It is hypothesized that
mutation in exon 2 of FOXP3 is involved in causing SLE, which is an important transcriptional
Factor of Regulatory T cells (Tregs), thought to be involved in the dysregulation of T cell production
and functional abilities. Association of HA with organ involvement was explored by multivariate
analysis. Ayyappan Robert Z. Harms J. Buckner N. Sarvetnick Medicine, Biology Frontiers in
Immunology 2019 TLDR Changes in the levels and relationships between ARFs link microbial
exposure and SLE, and approaches to reduce microbial exposure or to improve barrier function may
provide therapeutic strategies for SLE patients. In SLE, B-cell depletion is a potentially curative
approach, although a complete blockade of antibody production may increase susceptibility to
infection. Klein?gitelman Medicine Rheumatology and Therapy 2016 TLDR Current management of
SLE in children with a multidisciplinary approach is reviewed to provide patients with high quality of
care and to instill ownership of their disease process from a young age to prepare them to manage
this life-long illness.
Although quantitative and qualitative differences in Tregs have been described in SLE, studies to
date have shown conflicting results, and their role in SLE is still undefined. Over 90% survive for
more than 10 years Download Free PDF View PDF See Full PDF Download PDF Loading Preview
Sorry, preview is currently unavailable. Accapezzato, Daniele, Rosalba Caccavale, Maria Pia Paroli,
Chiara Gioia, Bich Lien Nguyen, Luca Spadea, and Marino Paroli. Expand 1,091 PDF Save Update
on the epidemiology of systemic lupus erythematosus: new spins on old ideas T. Accapezzato,
Daniele, Rosalba Caccavale, Maria Pia Paroli, Chiara Gioia, Bich Lien Nguyen, Luca Spadea, and
Marino Paroli. The repertoire of autoantibodies produced by autoreactive B cells, targets mainly
nuclear antigens. Semantic Scholar is a free, AI-powered research tool for scientific literature, based
at the Allen Institute for AI. The primary endpoint was the achievement of SRI-4 at week 52.
Expand 115 1 Excerpt Save Induction of Systemic Lupus Erythematosus with Tumor Necrosis
Factor Blockers Ekaterina Soforo M. Advances in the Pathogenesis and Treatment of Systemic
Lupus Erythematosus. Anti-histone antibodies are associated with drug-induced lupus, while anti-
ribosomal antibodies are associated with lupus. Often, it is associated with the presence of anti-U1-
ribonucleoprotein (U1-RNP) antibodies, because both bind small nuclear ribonucleoprotein (snRNP).
Systemic lupus erythematosus is a multisystem, auto-immune, connective-tissue disorder with a
broad range of clinical presentations. The first page of the PDF of this article appears above. The
major findings included anemia, leucopenia, lymphopenia and thrombocytopenia. Long-lived plasma
cells (LLPCs) derived from the terminal differentiation of B cells, are an important source of
autoantibody production in SLE. Anolik Medicine Journal of Rheumatology 2011 TLDR Extended
remissions are associated with prolonged reductions in the fractions of both memory B and T cells,
as well as downregulation of activation markers, including CD80 on B cells and CD40L, CD69, and
inducible costimulator (ICOS) on T cells. Systemic lupus erythematosus is a multisystem disorder
and hence, it can affect any tissues, organs and even systems of the body. Journal of Cardiovascular
Development and Disease (JCDD). Antiphospholipid antibodies, which include lupus anticoagulant,
anti-cardiolipin antibodies, and anti-?2 glycoprotein 1 antibody, are important indicators of vascular
inflammation and thromboembolic risk. Demographic and haematological parameters at diagnosis
and the last follow-up, disease manifestations, organ involvement and clinical hematological
complications were recorded. Antibodies are proteins that normally help protect the body from
invaders, like viruses and bacteria. Atallah Medicine The Cochrane database of systematic reviews
2006 TLDR This systematic review found one randomised controlled trial with a small number of
patients in the different clinical subgroups of neurological manifestation that seems that
cyclophosphamide is more effective in the treatment of neuropsychiatric involvement in systemic
erythematosus lupus compared with methylprednisolone. You will be able to get a quick price and
instant permission to reuse the content in many different ways. Conflicts of Interest The authors
declare no conflict of interest. Anti-nuclear antibodies (ANA) and anti-double stranded DNA (anti-
dsDNA) are reliable biomarkers for diagnosing SLE. Regulatory T cells (Tregs) are critical in
maintaining peripheral tolerance to self-antigens. Factors such as sunlight and drugs could trigger the
disorder, but no one cause has been identifi ed and systemic lupus erythematosus has a complex
genetic basis. All articles published by MDPI are made immediately available worldwide under an
open access license. No special. Understanding lupus, its symptoms, its treatment, and how a patient
might present with this disease is crucial for nurses.